Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial

OBJECTIVE: Serotonin reuptake inhibitors are frequently used in first-line treatments for patients with obsessive-compulsive disorder. Nevertheless, many of these patients do not respond well to initial therapy. The hypothesis of glutamatergic dysfunction in specific brain regions has been proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalkhali, Mohammadrasoul, Aram, Setareh, Zarrabi, Homa, Kafie, Moosa, Heidarzadeh, Abtin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947218/
https://www.ncbi.nlm.nih.gov/pubmed/27437007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947218/
https://www.ncbi.nlm.nih.gov/pubmed/27437007

Ejemplares similares